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Abstract
Infection of cattle with foot-and-mouth disease virus (FMDV) results in the development of long-term protective
antibody responses. In contrast, inactivated antigen vaccines fail to induce long-term protective immunity.
Differences between susceptible species have also been observed during infection with FMDV, with cattle often
developing persistent infections whilst pigs develop more severe symptoms and excrete higher levels of virus. This
study examined the early immune response to FMDV in naïve cattle after in-contact challenge. Cattle exposed to
FMDV were found to be viraemic and produced neutralising antibody, consistent with previous reports. In contrast
to previous studies in pigs these cattle did not develop leucopenia, and the proliferative responses of peripheral
blood mononuclear cells to either mitogen or third party antigen were not suppressed. Low levels of type 1
interferon and IL-10 were detected in the circulation. Taken together, these results suggest that there was no
generalised immunosuppression during the acute phase of FMDV infection in cattle.
Introduction
Foot-and-mouth disease (FMD) is an extremely conta-
gious and economically important disease of livestock.
Outbreaks in normally disease-free countries, such as the
UK in 2001 [1] and Japan in 2010 [2], have cost billions
of dollars in lost revenue. The current vaccines available
for use in endemic countries do not confer long-lasting
immunity and highly purified vaccine antigen is required
to distinguish between vaccinated and infected animals.
Understanding the complex relationship between virus
and host is vital in designing new vaccines that can be
targeted to those areas of the immune system most likely
to induce an effective response.
The causative agent, foot-and-mouth disease virus
(FMDV), spreads rapidly between animals and is quickly
disseminated within the host, presumably in order to
avoid the adaptive immune response (for an overview
see Golde et al. [3]).
In cattle, the primary sites of infection in aerosol trans-
mission are the nasopharangeal tissues [4], and associated
epithelial tissues [5]. Whilst several studies have examined
the host response to FMDV in swine [6-10], little is
known about the innate or adaptive response to FMDV in
cattle. Type 1 (alpha and beta) interferons (IFN) are
induced early in the innate immune response and are con-
sidered a dominant factor in shaping both innate and
adaptive immune responses [11]. Type 1 IFN certainly
seems to play a role in FMD pathogenesis in swine, and
Chinsamgaram et al. propose that during infection, type 1
IFN production is regulated by the leader protein of
FMDV (L
pro) [12]. However, prophylactic administration
of IFN by adenovirus vector prior to challenge, rapidly
induces a protective state in swine [13]. Two studies in
swine used direct inoculation of FMDV challenge methods
to identify a period of lymphopenia approximately 2 to 4
days post challenge that coincided with peak viraemia
[7,14]. In addition, in both studies the animals showed
suppression of T cell proliferation in response to mitogen
from day 1 to day 7 [14] and day 2 to day 5 or 8 depending
on the virus used [7]. Lymphopenia had also been corre-
lated with loss of plasmacytoid dendritic cell (PDC)
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cattle and Indian buffalo has provided limited evidence of
a transient lymphopenia immediately after infection [15].
In swine this immune suppression has also been linked
with elevated levels of IL-10 in serum [10]. IL-10 is widely
acknowledged to contribute to the anti-inflammatory
response and to the inhibition of cellular responses via a
variety of mechanisms (for a review see [16]). There is also
evidence that natural killer (NK) cells may be functionally
defective during infection [17].
In cattle, cytotoxic T lymphocytes (CTL) have been
shown to play a role in the FMDV immune response dur-
ing infection and vaccination [18,19] in a cross serotypic
manner [20]. Studies carried out on the proliferative
response of cattle peripheral blood lymphocytes following
vaccination showed a heterotypic reaction, indicating a
sharing of T cell epitopes [21]. When Garcia-Valcarcel et
al. inoculated an animal with FMDV, little proliferation
was seen until a subsequent re-challenge, when a cross
serotype response was observed [22].
The humoral response to FMDV is well documented,
with a rapid IgM response switching to IgG [23,24] which
confers protective immunity for many years [25]. It has
been suggested that this long-lasting antibody response is
in part due to the presence of viral particles held by folli-
cular dendritic cells in the lymph nodes of cattle, long
after the disease has been resolved [26]. Depletion of T
cell subsets by monoclonal antibodies showed that the
early antibody response to infection is T cell independent
[23].
T h ea i mo ft h ec u r r e n ts t u d yw a st od e f i n et h ee a r l y
innate and adaptive immune responses of cattle infected
with O serotype FMDV, after they were held in close
contact with cattle infected by intra-dermolingual chal-
lenge. Specifically, we determined whether there was gen-
eralised immune-suppression during the acute phase of
FMDV infection in cattle by monitoring the number of
leucocytes in the blood and assaying for inflammatory
and anti-inflammatory cytokines and suppression of the
T cell response. We also determined how rapidly FMDV-
specific humoral and cell-mediated immune responses
developed.
Materials and methods
Infection with FMDV
Male Holstein/Friesian cattle weighing approximately 150
kg were used for these studies. Two animals were
exposed to two separate intra-dermolingually challenged
cattle (1 × 10
5.7 TCID50 of cattle-adapted FMDV O UKG
34/2001) for 24 h. These inoculates formed no part of
the subsequent study and only the “naturally” exposed
animals will be referred to from here on. This procedure
was repeated in three sequential studies and the data pre-
sented here are an accumulation of these replicates
(replicate one = animal C1, replicate two = animals C2
and C3 and replicate three = C4 to C6).
Vaccination
Five Holstein/Friesian cattle (C7 to C11) were vaccinated
intramuscularly with 2 mL of O1Manisa vaccine (O1
Manisa vaccine from the UK FMDV emergency vaccine
bank).
Haematology
Blood samples were collected into anti-coagulant,
EDTA, and total leucocyte counts performed on the
same day as collection. Each sample was counted in tri-
plicate using a Sysmex haematology analyser (Sysmex F-
800 Sysmex corporation Kobe Japan).
Virus detection
Nucleic acid extraction and analysis was performed using
quantitative real-time reverse transcription polymerase
chain reaction (qRT-PCR) as described previously [27].
Virus-neutralising antibody test
Serum samples were tested for anti-FMDV neutralising
antibodies as described in the Office International des
Epizooties Manual of Diagnostic Tests and Vaccines for
Terrestrial Animals. Sera with titres greater than or
equal to 45 were considered to be positive [28].
Liquid-phase blocking ELISA
The liquid-phase blocking ELISA was performed as
described by Hamblin et al. [29]. Briefly; virus was
bound to immunosorbent plates by being trapped with
rabbit anti-O1 Manisa antibody. Test samples of bovine
sera were mixed with known standards of guinea pig
sera and the resultant competition determined by mea-
suring the amount of guinea pig serum bound to the
antigen.
Interferon assay
Type 1 IFN biological activity was measured in serum
samples using an Mx/chloramphenicol acetyltransferase
(Mx/CAT) promoter-reporter gene assay [30].
IL-10 ELISA
IL-10 was measured in serum following the method of
Kwong et al. [31]. Briefly, ELISA plates were coated with
anti-IL-10, cattle sera were applied in duplicate, along with
an IL-10 standard series, and detected with biotinylated
anti-bovine IL-10. This assay was repeated 3 times.
Vaccination with commercial bovine herpes virus-1 (BHV)
vaccine
Approximately one month prior to FMDV challenge,
animals C1 to C6 were immunised with Tracherine
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Page 2 of 11(Intervet, NL). Cattle were assayed for proliferative
response to BHV antigen immediately prior to challenge
with FMDV. However, the BHV-specific T cell prolifera-
tive response to the vaccine was variable; as a conse-
quence, only animals with T cell proliferative responses
consistently higher than 30 000 cpm prior to FMDV
infection (C1, C4, C5 and C6) were included in the ana-
lysis of whether FMDV infection significantly affected
specific recall responses.
Proliferation assays
Heparinised blood was diluted with phosphate-buffered
saline (PBS) (Invitrogen, Paisley, UK) and centrifuged
over Histopaque-1077 (Sigma) at 1328 g.P e r i p h e r a l
blood mononuclear cells (PBMC) were collected from
the interface, the red blood cells were lysed in erythrocyte
lysis buffer (155 mM ammonium chloride, 0.1 mM
EDTA and 10 mM sodium bicarbonate, pH 7.2) and
PBMC were washed three times with cold PBS. PBMC (2
×1 0
5 per well) in proliferation medium (RPMI 1640 sup-
plemented with 5% BVDV-free FCS, 1% non-essential
amino acids (Invitrogen) 1 mM sodium pyruvate (VWR,
Leicestershire, UK), 10 μg/mL gentamicin and 50 μM2 -
mercaptoethanol) were incubated with a range of anti-
gens; control and test antigens were added to each well.
Antigens included; medium alone, pokeweed mitogen
(2.5 μg/mL Sigma), inactivated FMDV antigen, mock
infected BHK-21 cell lysate and BHV antigen (heat inac-
tivated prior to use). FMDV antigen was kindly provided
by Merial Animal Health, (total antigen concentration
was known by the vaccine company but undisclosed).
Both FMDV and BHV antigens were previously titrated
for use in proliferation assays using PBMC from appro-
priately vaccinated cattle, with the final concentrations
used being 1/1000 for FMDV antigen and 1/100 for
BHV. The cultures were incubated for 5 days before
0.037 MBq [
3H] Thymidine (Amersham, Buckingham-
shire, UK) was added to each well. After a further over-
night incubation cells were harvested onto filter mats and
incorporated radioactivity was measured using a 1450
Microbeta counter (Wallac, Finland).
Statistical analysis
Linear mixed models were used to investigate the rela-
tionship between log10 CPM levels, antigen and time.
Model selection proceeded by stepwise deletion of non-
significant terms (as judged by the Akaike information
criterion), starting from a model including antigen, time
(as a factor) and an interaction between them; animal
was included as a random effect. A linear mixed model
was also used to compare IL-10 levels over time, with
the model including time (as a factor) as a fixed effect
and animal as a random effect.
Results
Viraemia and neutralising antibody responses after
challenge with FMDV
The onset and duration of viraemia after cattle have
been challenged with FMDV has been described pre-
viously, and the results obtained in this study are consis-
tent with previous reports [27,32]. In the six animals
studied, viraemia was first detected between 2 and 4
days after the animals were placed in contact with
FMDV needle challenged animals. Typical clinical signs
were observed in all the cattle from 2 to 4 days post
infection (data not shown), and viraemia was resolved in
all animals by day 7 (Figure 1a). All animals had sero-
converted to FMDV as demonstrated by liquid-phase
blocking ELISA (data not shown). All these animals had
detectable neutralising antibodies seven days after chal-
lenge (Figure 1b) and all were considered to have pro-
tective titres (> 45) by 14 days after challenge.
Total circulating leucocyte counts during the acute phase
of FMDV infection
Total circulating leucocyte counts did not significantly
fluctuate between day -2 prior to challenge and day 8
after challenge (Figure 2). In addition, the mean circulat-
ing leucocyte count of the cattle did not deviate above
or below the normal physiological range [33].
Whole lysed blood from two of the cattle (C2 and C3)
was also examined for any changes in CD4, CD8, WC1,
CD21 and NK cell leucocyte populations [7] but these
were not found to vary during the course of infection
(data not shown), which is in keeping with the results of
Juleff et al. [23].
Proliferative response of PBMC to mitogen (PWM) during
the acute phase of FMDV infection
Detailed analysis on the proliferative response to Poke-
weed mitogen (PWM) in all six animals (C1 to C6) was
carried out (Figure 3) (there were minor variations in
sample days due to unavoidable differences in sampling
schedules between replicates). Marked proliferation,
(greater than 200 000 cpm), of PBMC to PWM was
detected at various time-points between day -1 prior to
FMDV infection and day 19 after challenge.
Development of FMDV-specific T cell responses during
the resolution of acute infection
FMDV-specific T cell responses were measured by pro-
liferation of PBMC to virus antigen in animals C1 to C6
(Figure 3). Although there appears to be a small rise in
proliferation to FMDV antigen at day 19 in animals C2
to C6, it was not found to be significant when the data
for all animals were exposed to statistical examination.
More precisely, there was no significant (P =0 . 5 7 )
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Page 3 of 11Figure 1 Cattle infected with FMDV were viraemic during acute infection and developed neutralising antibodies. A. Onset and duration
of viraemia of all six FMDV challenged cattle used in this study as obtained by quantitative real-time reverse transcription polymerase chain
reaction (qRT-PCR). B. Neutralising antibody titre in serum of infected cattle. Sera with titres greater than or equal to 45 were considered to be
positive (dotted line).
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Page 4 of 11Figure 2 Total circulating leucocyte counts from all six FMDV challenged cattle (C1 to C6) during the acute phase of FMDV infection.
Blood samples were collected into EDTA, and total leucocyte counts performed on the same day as collection. Counts were performed in
triplicate on each sample. (N = 6) Lines show 2X STDEV of day 0.
Figure 3 Proliferative response of PBMC to mitogen during the acute phase of FMDV infection. PBMC from infected cattle were assayed
for proliferation following in vitro incubation with Pokeweed mitogen and FMDV antigen in triplicate. Data shown is the mean of animals in
each replicate (C1, C2 and C3 and C4 to C6) for each time point. Error bars show STDEV of all animals in each group for each time point.
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Page 5 of 11interaction between time and antigen, and log10 CPM
levels did not change significantly (P = 0.31) over time
for any of the antigens (medium, FMDV or PWM).
There was however, a significant (P < 0.001) difference
in log10 CPM levels amongst antigens, with levels for
PWM being significantly higher than for FMDV or med-
ium (which did not differ significantly (P =0 . 0 8 )f r o m
one another).
Analysis of established specific memory T cell responses
during the acute phase of FMDV infection
Vaccination with BHV resulted in variable T cell
responses in individual animals (Figure 4), but log10
CPM levels were significantly (P < 0.001) higher for
BHV compared with medium and mock (log10 CPM
levels did not differ significantly (P = 0.71) between
mock and medium). However, for BHV, there was no
significant change in log10 CPM levels at any time point
post FMDV infection.
Development of FMDV-specific T cell responses after
vaccination
Five cattle (C7 to C11) were vaccinated with O1 Manisa
commercial vaccine and examined for T cell responses by
PBMC proliferation assays (Figure 5). After day 21 animals
C8, C9 and C10 were boosted. An increase in proliferative
response was seen in these animals with counts per min-
ute rising to approximately 300 000, 400 000 and 500 000
cpm respectively. The T cell response to FMDV antigen
following vaccination was variable in individual cattle, but
by inspection, when a response was seen, it was always
earlier and of greater magnitude than after infection (it is
not appropriate to perform statistical analyses between the
studies in Figures 3 and 5).
Figure 4 Proliferative response to third party antigen during the acute phase of FMDV infection. PBMC from infected cattle (previously
vaccinated with BHV) were assayed for proliferation following in vitro incubation with BHV antigen, in triplicate. Due to the variation in
magnitude of response to BHV, the data are displayed separately for each of the cattle C1, C4, C5 and C6. Error bars show STDEV of the mean of
three wells for each time point.
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Page 6 of 11Detection of circulating type 1 IFN during the acute
phase of FMDV infection
Type 1 IFN was assayed from the sera of six infected cattle
(Figure 6). Production of type 1 IFN following infection
with FMDV was variable, with the peak values varying
between 1 and 14 international units/mL (IU/mL).
Detection of circulating IL-10 during the acute phase of
FMDV infection
Six cattle (C1 to C6), were assayed for circulating IL-10
before, during, and after the acute phase of FMDV infec-
tion (Day -2 through to day 8, Figure 7). Low, but statisti-
cally significant compared to pre-challenge (P < 0.03),
levels of IL-10 were detected in all animals, rising over
time, reaching a peak on average of 1.35 IU/mL between
day 3 and 4, after which they declined.
Discussion
Early studies by Cunliffe et al. [25] established the long
duration of immunity following infection with FMDV in
cattle. In contrast, current commercial vaccination proto-
cols require regular re-inoculation to maintain immunity.
Analysing the differences in the immune response in the
natural host during these two processes may lead to the
design of more effective vaccines.
By exposing six cattle to FMDV this study aimed to;
investigate whether a generalised suppressive state is
induced, compare early T cell responses to those of vacci-
nates, and examine the expression of key immune-modula-
tory cytokines.
After natural exposure to FMDV, viraemia is typically
detectable within 2 to 3 days followed by clinical signs [27].
Production of high titres of neutralising antibodies can be
detected as early as six days following natural infection, by
a process shown previously to be T cell independent in cat-
tle [23]. These previous observations were confirmed in all
of the cattle used in this study. Compared to the rapid pro-
duction of antibody, significant FMDV-specific T cell
responses (assayed by proliferation of PBMC) were not
observed following natural infection. These data are sup-
ported by other cattle studies, with no FMDV-specific T
cell response detectable up to 32 days post exposure in
some cases (M. Windsor unpublished data). We also inves-
tigated whether there was any loss of mitogen or specific
antigen induced T cell proliferative responses during the
course of acute infection. Abrogation of proliferation of
PBMC to mitogen in pigs occurs between 2 and 8 days but
most noticeably at day 5 after needle challenge [7]. Follow-
ing natural challenge, peak viraemia in cattle occurs at
least two days later than needle challenge [34], which is
Figure 5 Proliferative response to FMDV antigen in vaccinated cattle. PBMC from five cattle vaccinated with FMDV O1 Manisa commercial
vaccine were assayed for proliferative response to FMDV antigen. The kinetics of the proliferative response for each animal for the first 21 days
post vaccination are shown. Error bars show STDEV for each of the five animals at each time point.
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Page 7 of 11consistent with the pattern of viraemia in our study. We
did not observe any loss of mitogen or specific antigen
induced T cell proliferative responses on day 6 post-infec-
tion. Even though a specific T cell response to FMDV
could not be detected during the acute stages of infection,
the T cell proliferative responses to mitogen and a third
party antigen (BHV) were unaffected.
In a previous study using bovine dendritic cells (DC),
Robinson et al. [35] showed that, in vitro, DC infection
was enhanced by the formation of FMDV immune com-
plexes. These data suggest that as FMDV rapidly loses
its ability to infect susceptible cells due to increasing
neutralising antibody titres, it gains the capacity to infect
immune cells via CD32 (FcgR). These findings by Robin-
son et al. suggest that infection and killing of DC by
immune-complexed FMDV may be responsible in part
for the delayed FMDV-specific T cell proliferative
response [35]. Clearly, it is not the ability of the T cells
to respond that is affected, as evidenced by the mainte-
nance of established T cell responses to mitogen and
third party antigen.
The FMDV-specific T cell proliferative response in the
five vaccinates was variable. Where an effective response
to antigen was seen, it was of a high magnitude and
detectable from seven days post vaccination. It should
be noted that although the initial response was low in
some cattle, they all subsequently went on to develop a
similar magnitude of T cell response following a booster
vaccination, showing that there was no underlying
impairment of the response in these animals.
Transient lymphopenia has been observed in swine
following infection with FMDV which correlated with
the virulence of the isolate used [7]. In cattle, we were
unable to detect any evidence of lymphopenia, with the
numbers of leucocytes remaining constant and within
physiological ranges during the period of viraemia and
clinical FMD. Leukocyte subsets were also examined in
whole lysed blood in two of the animals and no changes
were observed, confirming our previous observations
[23]. This contrasts studies in pigs, where a significant
loss of circulating CD4
+ and CD8
+ T cells was observed
[7].
Studies in pigs have found high levels of type 1 IFN
following experimental infection with several FMDV iso-
lates [10,36], which correlates with immune suppression.
Due to the different methods of quantification used in
these studies, it is problematic to compare the levels of
IFN produced. In cattle we have measured the specific
Figure 6 Type 1 IFN in sera of cattle during the acute phase of FMDV infection. Six cattle were assayed for circulating biologically active
type 1 IFN by Mx CAT reporter assay.
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Page 8 of 11activity of type 1 IFN (in international units), whereas
total circulating type 1 IFN protein was measured in pig
serum. However, this IFN is not necessarily biologically
active. Several sources, including manufacturers’ data
sheets, give type 1 IFN specific activity (cross species) at
b e t w e e n1a n d3×1 0
8 IU/mg of total IFN. Using this
calculation we can speculatively compare type 1 IFN in
the sera of pigs and cattle during FMDV infection, and
postulate that pigs do indeed produce more IFN than
the cattle in this study. The most compatible study in
pigs was performed by Nfon et al., who used O1Campos
challenge [10]. At least 9 fold more type 1 IFN was pro-
duced in pigs compared to our results in cattle. In pigs,
IFN clearly has an important role to play in the resolu-
tion of infection, as the administration of type 1 IFN in
a viral vector protects against subsequent challenge with
FMDV [37].
Our study implies that cattle produce very little type 1
I F Ni nc o m p a r i s o nt op i g s ,w h i c hi si nk e e p i n gw i t h
previous studies [38], yet cattle still resolve the disease
effectively. Depletion of CD4
+ cells in cattle during
infection further reduces circulating type I IFN, but
infection is still resolved [23], indicating that the pre-
sence of type 1 IFN in the circulation may not have any
bearing on the resolution of disease. The IFN detected
in the circulation during FMDV infection in cattle is
t h o u g h tt ob ep r o d u c e db yC D 4
+ PDCs interacting with
immune-complexed virus [39]. The PDCs found in cat-
tle secondary lymphoid tissuea r ec a p a b l eo fp r o d u c i n g
large amounts of IFN in vitro [39]. It is possible there-
fore, that IFN does play a local role at the sites of infec-
tion such as lesions, or in the lymph nodes, and that the
IFN found in the circulation is derived from these high
concentration sources. Summerfield et al. and Nfon et
al. found large numbers of circulating PDCs in pigs
[10,40] in comparison to the low numbers detectable in
cattle. Nfon also found that these PDCs were function-
ally impaired during the latter stages of infection with
FMDV.
Low levels of IL-10, corresponding with the peak of
clinical signs, were found in the serum of the cattle stu-
died. Whilst IL-10 does appear to play a role in immune
suppression in pigs during infection with FMDV [8], it
is most commonly associated with the maintenance of
chronic infections such as Hepatitis C in humans
[41,42] and Mycobacterium Bovis in cattle [43]. Studies
in mice have shown that FMDV infected DC can stimu-
late splenic CD9
+ B cells to produce T-independent
neutralising IgM antibodies, via an IL-10 dependent pro-
cess [44]. We propose that the absence of leucopenia
Figure 7 IL-10 in sera of cattle during the acute phase of FMDV infection. Six cattle were assayed for circulating IL-10 by ELISA from day -2
to day 8 post infection. Data shown is the mean of all six animals (C1 to C6). Error bars show STDEV of the mean.
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Page 9 of 11and immunosuppression in cattle, during acute FMDV
infection, is associated with the low levels of type 1 IFN
and IL-10. These differences in cytokine profile between
pigs and cattle may also explain why, in general, more
severe clinical signs are seen in pigs infected with
FMDV [45].
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